Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Disease Markers|December 31, 2019
Vimentin 3 Allows Differentiation between Normozoospermia and OligoasthenoteratozoospermiaTimo Funke, Melanie von Brandenstein, Pia Paffenholz, et al.
The American Journal of Pathology|May 28, 2005
Absence of immunoglobulin class switch in primary lymphomas of the central nervous systemManuel Montesinos-Rongen, Roland Schmitz, Cornelius Courts, et al.
The Journal of Molecular Diagnostics : JMD|August 4, 2020
Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral BiopsyManuel Montesinos-Rongen, Anna Brunn, Armin Tuchscherer, et al.
Biomedicines|April 23, 2022
COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male FertilityHeike Goebel, Barbara Koeditz, Manuel Huerta, et al.
Blood|April 3, 2013
CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemiaOleg Fedorchenko, Marius Stiefelhagen, Abdul A Peer-Zada, et al.
Neuro-Oncology|December 22, 2021
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastasesAnna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Blood|November 3, 2012
Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factorNina Reinart, Phuong-Hien Nguyen, Jorge Boucas, et al.
Journal of Neuropathology and Experimental Neurology|March 16, 2007
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expressionCornelius Courts, Manuel Montesinos-Rongen, Jose Ignacio Martin-Subero, et al.
Blood|November 10, 2023
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAJan-Michel Heger, Julia Mattlener, Jessica Schneider, et al.
Clinical Nuclear Medicine|January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor RelapseGarry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Pageof 5